国富创新(00290.HK) 公布,2024年11月4日至今年1月15日期间,于公开市场出售今海医疗科技(02225.HK) 合共1,886万股,总代价2,698万元,相当于每股平均价1.43元;及于2月21日,向一名独立第三方出售今海医疗科技合共4,294万股,总代价6,012万元,相当于每股作价1.4元。估计出售确认收益约2,244万元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-02-21 16:25。)
AASTOCKS新闻Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.